Drug Trial Radar · NCT05859698
Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
Last checked: Nov 20, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
59
Actual
Start
May 9, 2023
Primary completion
Dec 27, 2024
Study completion Dec 27, 2024
Sponsor
- Lead sponsor
- Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
- Sponsor type
- Industry
- First posted
- May 16, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the effectiveness of valbenazine on patient- and clinician-reported outcomes assessing health-related quality of life, functioning, and treatment effect in participants with tardive dyskinesia (TD) who are receiving valbenazine for up to 24 weeks.
Conditions
- Schizophrenia
- Schizoaffective Disorder
- Bipolar Disorder
- Major Depressive Disorder
- Tardive Dyskinesia
Interventions
ValbenazineDrug
Valbenazine capsules for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Tardive Dyskinesia Impact Scale (TDIS) Total Score at Week 24Time frame: Baseline, Week 24
- Change From Baseline in the Sheehan Disability Scale (SDS) Items 1, 2, and 3 Score at Week 24Time frame: Baseline, Week 24
- Change From Baseline in the Euro Quality of Life Visual Analogue Scale (EQ-VAS) Score at Week 24Time frame: Baseline, Week 24
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Neurocrine Clinical Site
Bryant, Arkansas
Neurocrine Clinical Site
Anaheim, California
Neurocrine Clinical Site
Orange, California
Neurocrine Clinical Site
Torrance, California
Neurocrine Clinical Site
Bonita Springs, Florida
Neurocrine Clinical Site
Miami, Florida
Neurocrine Clinical Site
Miami Lakes, Florida
Neurocrine Clinical Site
Okeechobee, Florida
Neurocrine Clinical Site
Tampa, Florida
Neurocrine Clinical Site
Atlanta, Georgia
Neurocrine Clinical Site
Augusta, Georgia
Neurocrine Clinical Site
Marietta, Georgia
Neurocrine Clinical Site
Lincoln, Nebraska
Neurocrine Clinical Site
Beechwood, Ohio
Neurocrine Clinical Site
Oklahoma City, Oklahoma
Neurocrine Clinical Site
DeSoto, Texas
Neurocrine Clinical Site
El Paso, Texas
Neurocrine Clinical Site
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.